Application of Real-World Evidence to Support FDA Regulatory Decision Making

被引：0
|
作者：
Vipada Khaowroongrueng [1 ]
Tae-Eun Kim [2 ]
Sang-In Park [3 ]
Kwang-Hee Shin [4 ]
机构：
[1] The Government Pharmaceutical Organization,Research Development and Innovation Department
[2] Konkuk University Medical Center,Department of Clinical Pharmacology
[3] Kangwon National University,Department of Pharmacology, College of Medicine
[4] Kyungpook National University,College of Pharmacy, Research Institute of Pharmaceutical Sciences
[5] Kyungpook National University,Infectious Disease Healthcare
来源：
The AAPS Journal | / 27卷 / 4期
关键词：
FDA; real-world evidence; regulatory decision making;
D O I：
10.1208/s12248-025-01082-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The application of real-world evidence in drug regulatory decision-making
    Wicherski, Julia
    Haenisch, Britta
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2024, 67 (02) : 255 - 256
  • [2] Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
    Burcu, Mehmet
    Dreyer, Nancy A.
    Franklin, Jessica M.
    Blum, Michael D.
    Critchlow, Cathy W.
    Perfetto, Eleanor M.
    Zhou, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1228 - 1235
  • [3] Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World
    Burns, Leah
    Le Roux, Nadege
    Kalesnik-Orszulak, Robert
    Christian, Jennifer
    Hukkelhoven, Mathias
    Rockhold, Frank
    O'Donnell, John
    CLINICAL THERAPEUTICS, 2022, 44 (03) : 420 - 437
  • [4] Real-world evidence for regulatory decision-making: updated guidance from around the world
    Burns, Leah
    Le Roux, Nadege
    Kalesnik-Orszulak, Robert
    Christian, Jennifer
    Dudinak, Jennifer
    Rockhold, Frank
    Khozin, Sean
    O'Donnell, John
    FRONTIERS IN MEDICINE, 2023, 10
  • [5] The relevance of the real-world evidence in research, clinical, and regulatory decision making
    Costa, Valton
    Custodio, Marcelo Graziano
    Gefen, Eran
    Fregni, Felipe
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [6] Optimizing real-world evidence studies for regulatory decision-making and impact assessment in pharmacovigilance
    Ioakeim-Skoufa, Ignatios
    Atkins, Kerry
    Hernandez-Rodriguez, Miguel angel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [7] The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics
    Klonoff, David C.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (02): : 345 - 349
  • [8] Die Anwendung von Real-world-Evidenz in Entscheidungsprozessen der ArzneimittelregulationThe application of real-world evidence in drug regulatory decision-making
    Julia Wicherski
    Britta Haenisch
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2024, 67 (2) : 149 - 154
  • [9] Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
    Feinberg, Bruce A.
    Gajra, Ajeet
    Zettler, Marjorie E.
    Phillips, Todd D.
    Phillips, Eli G., Jr.
    Kish, Jonathan K.
    VALUE IN HEALTH, 2020, 23 (10) : 1358 - 1365
  • [10] Real-world evidence to support health technology assessment and payer decision making: is it now or never?
    Murphy, Linda A.
    Akehurst, Ron
    Cunningham, David
    de Pouvourville, Gerard
    Sola-Morales, Oriol
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2025, 41 (01)
12345